beta

AEMD

Aethlon Medical, Inc.

Aemd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.

Market Cap: 2.87 Million

Primary Exchange: NASDAQ

Website: http://www.aethlonmedical.com

Shares Outstanding: 1.44 Million

Float: 1.38 Million

Dividend: (%)

Beta: 0.0993451252301758

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 1796 trading days

From: 2014-11-24 To: 2019-12-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-04-14 50.0 1.0 50.0
Data provided by IEX Cloud